BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18246197)

  • 1. Regulation of myeloproliferation and M2 macrophage programming in mice by Lyn/Hck, SHIP, and Stat5.
    Xiao W; Hong H; Kawakami Y; Lowell CA; Kawakami T
    J Clin Invest; 2008 Mar; 118(3):924-34. PubMed ID: 18246197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inositol 5'-phosphatase SHIP-1 and the Src kinase Lyn negatively regulate macrophage colony-stimulating factor-induced Akt activity.
    Baran CP; Tridandapani S; Helgason CD; Humphries RK; Krystal G; Marsh CB
    J Biol Chem; 2003 Oct; 278(40):38628-36. PubMed ID: 12882960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHIP represses the generation of IL-3-induced M2 macrophages by inhibiting IL-4 production from basophils.
    Kuroda E; Ho V; Ruschmann J; Antignano F; Hamilton M; Rauh MJ; Antov A; Flavell RA; Sly LM; Krystal G
    J Immunol; 2009 Sep; 183(6):3652-60. PubMed ID: 19710468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1.
    Harder KW; Quilici C; Naik E; Inglese M; Kountouri N; Turner A; Zlatic K; Tarlinton DM; Hibbs ML
    Blood; 2004 Dec; 104(13):3901-10. PubMed ID: 15339845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct activation of STAT5 by ETV6-LYN fusion protein promotes induction of myeloproliferative neoplasm with myelofibrosis.
    Takeda Y; Nakaseko C; Tanaka H; Takeuchi M; Yui M; Saraya A; Miyagi S; Wang C; Tanaka S; Ohwada C; Sakaida E; Yamaguchi N; Yokote K; Hennighausen L; Iwama A
    Br J Haematol; 2011 Jun; 153(5):589-98. PubMed ID: 21492125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lyn- and PLC-beta3-dependent regulation of SHP-1 phosphorylation controls Stat5 activity and myelomonocytic leukemia-like disease.
    Xiao W; Ando T; Wang HY; Kawakami Y; Kawakami T
    Blood; 2010 Dec; 116(26):6003-13. PubMed ID: 20858858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Src family kinases are important negative regulators of G-CSF-dependent granulopoiesis.
    Mermel CH; McLemore ML; Liu F; Pereira S; Woloszynek J; Lowell CA; Link DC
    Blood; 2006 Oct; 108(8):2562-8. PubMed ID: 16772601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors.
    DeKoter RP; Walsh JC; Singh H
    EMBO J; 1998 Aug; 17(15):4456-68. PubMed ID: 9687512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absence of Hck, Fgr, and Lyn tyrosine kinases augments lung innate immune responses to Pneumocystis murina.
    Nelson MP; Metz AE; Li S; Lowell CA; Steele C
    Infect Immun; 2009 May; 77(5):1790-7. PubMed ID: 19255189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of granulocyte-macrophage colony-stimulating factor signaling and microglial proliferation by anti-CD45RO: role of Hck tyrosine kinase and phosphatidylinositol 3-kinase/Akt.
    Suh HS; Kim MO; Lee SC
    J Immunol; 2005 Mar; 174(5):2712-9. PubMed ID: 15728479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lyn, PKC-delta, SHIP-1 interactions regulate GPVI-mediated platelet-dense granule secretion.
    Chari R; Kim S; Murugappan S; Sanjay A; Daniel JL; Kunapuli SP
    Blood; 2009 Oct; 114(14):3056-63. PubMed ID: 19587372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms.
    Mager LF; Riether C; Schürch CM; Banz Y; Wasmer MH; Stuber R; Theocharides AP; Li X; Xia Y; Saito H; Nakae S; Baerlocher GM; Manz MG; McCoy KD; Macpherson AJ; Ochsenbein AF; Beutler B; Krebs P
    J Clin Invest; 2015 Jul; 125(7):2579-91. PubMed ID: 26011644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of murine macrophages via TLR2 and TLR4 is negatively regulated by a Lyn/PI3K module and promoted by SHIP1.
    Keck S; Freudenberg M; Huber M
    J Immunol; 2010 May; 184(10):5809-18. PubMed ID: 20385881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHIP deficiency enhances HSC proliferation and survival but compromises homing and repopulation.
    Desponts C; Hazen AL; Paraiso KH; Kerr WG
    Blood; 2006 Jun; 107(11):4338-45. PubMed ID: 16467196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SHIP is required for a functional hematopoietic stem cell niche.
    Hazen AL; Smith MJ; Desponts C; Winter O; Moser K; Kerr WG
    Blood; 2009 Mar; 113(13):2924-33. PubMed ID: 19074735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristic expression of Hck in human B-cell precursors.
    Taguchi T; Kiyokawa N; Sato N; Saito M; Fujimoto J
    Exp Hematol; 2000 Jan; 28(1):55-64. PubMed ID: 10658677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the activated (Y501-F501) hck tyrosine kinase in 32Dcl3 myeloid cells prolongs survival in the absence of IL-3 and blocks granulocytic differentiation in response to G-CSF.
    English BK
    J Leukoc Biol; 1996 Nov; 60(5):667-73. PubMed ID: 8929559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role of Lyn kinase in inhibition of neutrophil apoptosis by granulocyte-macrophage colony-stimulating factor.
    Wei S; Liu JH; Epling-Burnette PK; Gamero AM; Ussery D; Pearson EW; Elkabani ME; Diaz JI; Djeu JY
    J Immunol; 1996 Dec; 157(11):5155-62. PubMed ID: 8943427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of SHIP in macrophages.
    Sly LM; Ho V; Antignano F; Ruschmann J; Hamilton M; Lam V; Rauh MJ; Krystal G
    Front Biosci; 2007 May; 12():2836-48. PubMed ID: 17485263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic segregation of inflammatory lung disease and autoimmune disease severity in SHIP-1-/- mice.
    Maxwell MJ; Duan M; Armes JE; Anderson GP; Tarlinton DM; Hibbs ML
    J Immunol; 2011 Jun; 186(12):7164-75. PubMed ID: 21572033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.